Full-Time

Screening Quality Control/Data Entry Associate

Posted on 11/22/2025

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Montreal, QC, Canada

In Person

Category
Clerical & Data Entry (1)
Requirements
  • DEC completed in a related field.
  • Excellent communications skills in both French and English.
  • Able to multi-task, prioritize.
  • Excellent organizational skills.
  • Strong attention to detail.
  • Proven ability to work as part of a team in a very fast paced, deadline-driven environment.
  • Strong MS Office skills including Word, Excel, PowerPoint and Outlook and familiarity with HRMS systems.
  • Fluency in English is an essential requirement for the position of Quality Control/Data Entry Associate including, but not limited to, for the following reasons: The requirement to have study protocols, designs and clinical research documents written and documented in English as required by industry regulatory agencies.
Responsibilities
  • Performs internal review and UAT of source used to capture data during Screening. Maintain tracking tools to ensure review of screening CRF and data entry milestones are met.
  • Generate Delegation of Authority log and Protocol Training Report and other documents related for Screening.
  • Create/Review/Update Screening Information and ICF Discussion Reference Sheet and other documents related.
  • Creates, maintains Screening and Enrollment Log for all studies.
  • Performs data entry of clinical trial data into electronic data capture (EDC) software in compliance with protocol/SOP and EDC guidelines.
  • Identify error trends and report trending to departmental management.
  • Record, track and ensure the resolution of data queries in timely manner.
  • Act as a resource and provide support when necessary
  • Maintain and advocate a high level of quality and customer service within the department.
  • Ensure the confidentiality of clinical trial volunteers and sponsors is respected.
Desired Qualifications
  • Related work experience preferred.
  • Experience with eSource systems preferred.

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Simplify Jobs

Simplify's Take

What believers are saying

  • Biotech sponsors need fewer vendors for early development, shortening timelines and reducing handoffs.
  • Certara integration strengthens proof-of-mechanism decisions and improves go-no-go confidence.
  • Novo Holdings backing supports expansion into international markets and deeper platform investment.

What critics are saying

  • ICON, Labcorp, and Parexel can bundle similar speed claims with larger global reach.
  • Low biotech funding pressures utilization, and idle clinics quickly crush CRO/CDMO margins.
  • Any manufacturing or data-integrity failure can halt multiple sponsor programs and trigger client exits.

What makes Altasciences unique

  • Founded in 1992, Altasciences evolved from Algorithme Pharma into an integrated CRO/CDMO.
  • Nine North American facilities support preclinical, clinical, bioanalytical, and manufacturing services.
  • The May 2026 Certara partnership adds model-informed drug development directly into execution.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Altasciences who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

4%
GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.

INACTIVE